In the United States the ClariVein® IC is intended for the infusion of physician-specified agents in the peripheral vasculature. For Rx only.
US Patents 7,862,575, 7,967,834, 8,465,508, 8,686,645, various issued foreign patents and other United States and foreign patents pending.
© 2019 ClariVein powered by Merit Medical. All rights reserved.